< Back to Listing

Infographic | Medication Safety: Switching P2Y12 Inhibitors

Download File

Description:

Infographic | Medication Safety: Switching P2Y12 Inhibitors

Drug interactions between P2Y12 Inhibitors can lead to inadequate platelet inhibition and risk of throbotic complications. This infographic advises how to best switch between platelet inhibitors.

Infographic Image | Click To Enlarge

Citations

  1. https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.117.031164
  2. http://www.onlinejacc.org/content/56/13/1017
  3. http://www.onlinejacc.org/content/63/15/1500
  4. http://interventions.onlinejacc.org/content/9/11/1089
  5. https://www.nejm.org/doi/full/10.1056/NEJMoa0904327
  6. https://www.nejm.org/doi/full/10.1056/NEJMoa0706482
  7. https://www.ahajournals.org/doi/10.1161/JAHA.114.000849
  8. https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.118.033983
  9. Cerrato E, Bianco M, Bagai A, et al. Short Term Outcome Following Acute Phase Switch Among P2Y12 Inhibitors in Patients Presenting with Acute Coronary Syndrome Treated with PCI: A Systematic Review and Meta-analysis Including 22,500 Patients from 14 Studies. IJC Heart & Vasculature 2019;22:39-45.

All infographics should be credited to "American College of Cardiology."

More ACC Infographics

Date: January 01, 2022    

Clinical Topics: Acute Coronary Syndromes

Keywords: Acute Coronary Syndrome, Vascular Diseases, Platelet Aggregation Inhibitors, Thromboembolism